ENTG vs LRCX
Entegris, Inc. and Lam Research, both Technology
Lam Research is the larger company at $487B against $27B. On trailing earnings LRCX is the cheaper of the two at a P/E of 55.4 against 82.9, a gap that is only a bargain if the two are growing at similar rates. Over the past year LRCX returned +154% against +78% for ENTG. The RyuScore puts LRCX ahead, 60 against 34 out of 100.
| Figure | ENTG | LRCX |
|---|---|---|
| Last close | $166 | $319 |
| Market cap | $27B | $487B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 82.9 | 55.4 |
| Dividend yield | 0.2% | 0.3% |
| 1-year return | +78% | +154% |
| 5-year return | +32% | +452% |
| RyuScoresector-relative, 1–10 | 34/100 | 60/100 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Entegris, Inc.
Revenue of $883M in Q2 2026, net income $94M. Its largest reported line is Advanced Purity Solutions, 58% of the disclosed total.
Lam Research
Revenue of $6.7B in Q4 2026, net income $2.3B. Its largest reported line is Taiwan, 28% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or see the correlation.